ロード中...
Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
BACKGROUND: Acromegaly is a rare disease primarily caused by growth hormone (GH)-secreting pituitary adenomas, and its treatment is costly. Moreover, some patients are unresponsive to treatment. Hence, there are increasing efforts to develop new drugs with improved effectiveness for this disease. BI...
保存先:
| 出版年: | Endocrinol Metab (Seoul) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Endocrine Society
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7090307/ https://ncbi.nlm.nih.gov/pubmed/32207278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.35.1.177 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|